A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris

Abstract

Summary Background Various treatments for acne vulgaris exist, but little is known about their comparative effectiveness in relation to acne severity. Objectives To identify best treatments for mild‐to‐moderate and moderate‐to‐severe acne, as determined by clinician‐assessed morphological features. Methods We undertook a systematic review and network meta‐analysis of randomized controlled trials (RCTs) assessing topical pharmacological, oral pharmacological, physical and combined treatments for mild‐to‐moderate and moderate‐to‐severe acne, published up to May 2020. Outcomes included percentage change in total lesion count from baseline, treatment discontinuation for any reason, and discontinuation owing to side‐effects. Risk of bias was assessed using the Cochrane risk‐of‐bias tool and bias adjustment models. Effects for treatments with ≥ 50 observations each compared with placebo are reported below. Results We included 179 RCTs with approximately 35 000 observations across 49 treatment classes. For mild‐to‐moderate acne, the most effective options for each treatment type were as follows: topical pharmacological – combined retinoid with benzoyl peroxide (BPO) [mean difference 26·16%, 95% credible interval (CrI) 16·75–35·36%]; physical – chemical peels, e.g. salicylic or mandelic acid (39·70%, 95% CrI 12·54–66·78%) and photochemical therapy (combined blue/red light) (35·36%, 95% CrI 17·75–53·08%). Oral pharmacological treatments (e.g. antibiotics, hormonal contraceptives) did not appear to be effective after bias adjustment. BPO and topical retinoids were less well tolerated than placebo. For moderate‐to‐severe acne, the most effective options for each treatment type were as follows: topical pharmacological – combined retinoid with lincosamide (clindamycin) (44·43%, 95% CrI 29·20–60·02%); oral pharmacological – isotretinoin of total cumulative dose ≥ 120 mg kg−1 per single course (58·09%, 95% CrI 36·99–79·29%); physical – photodynamic therapy (light therapy enhanced by a photosensitizing chemical) (40·45%, 95% CrI 26·17–54·11%); combined – BPO with topical retinoid and oral tetracycline (43·53%, 95% CrI 29·49–57·70%). Topical retinoids and oral tetracyclines were less well tolerated than placebo. The quality of included RCTs was moderate to very low, with evidence of inconsistency between direct and indirect evidence. Uncertainty in findings was high, in particular for chemical peels, photochemical therapy and photodynamic therapy. However, conclusions were robust to potential bias in the evidence. Conclusions Topical pharmacological treatment combinations, chemical peels and photochemical therapy were most effective for mild‐to‐moderate acne. Topical pharmacological treatment combinations, oral antibiotics combined with topical pharmacological treatments, oral isotretinoin and photodynamic therapy were most effective for moderate‐to‐severe acne. Further research is warranted for chemical peels, photochemical therapy and photodynamic therapy for which evidence was more limited. What is already known about this top...

Cost-effectiveness of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris

“…In our analysis, we utilised efficacy and discontinuation data derived from a large systematic review and NMA. 5 This approach combines direct (i.e. head-to-head comparisons) and indirect evidence (comparisons through e.g.…”

“…In our analysis, we used efficacy and discontinuation data derived from a large systematic review and NMA 5 . This approach combines direct (i.e.…”

“…Relative effects on efficacy [percentage change in total acne lesion count from baseline (%CFB)], discontinuation due to any reason and discontinuation due to side effects were obtained from the source NMA 5 (Supplementary Data S2). For mild‐to‐moderate acne, the economic analysis considered only treatments with evidence of efficacy in a bias‐adjusted NMA, owing to indication of small study bias 5 …”

“…For mild-to-moderate acne, the economic analysis considered only treatments with evidence of efficacy in a bias-adjusted NMA, owing to indication of small study bias. 5 To obtain absolute effects for each treatment and outcome, we combined NMA relative effects with absolute effects of a reference treatment. We selected adapalene (topical retinoid) as the reference treatment based on data availability.…”

Tratamento da Acne com Ozonioterapia: Uma Revisão da Literatura

“…Classifica-se como acne de início tardio e acne persistente. O tipo persistente é o mais comum, representando 70% a 80% dos casos, e é definida pela manifestação inaugural após os 25 anos de idade, com uma prevalência de cerca de 20% a 30%" (COSTA; VELHO, 2018;HOPKINS et al, 2022;MAVRANEZOULI, 2022).…”